title

Mayo Clinic Talks

Mayo Clinic

52
Followers
80
Plays
Mayo Clinic Talks

Mayo Clinic Talks

Mayo Clinic

52
Followers
80
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Stay on top of your primary care practice with podcasts from your colleagues at Mayo Clinic. Curated. Portable. Trusted. Offering continuing medical education - CME - for select episodes. Family medicine, primary care, general internal medicine topics for physicians, nurse practitioners and physician assistants.

Latest Episodes

Mayo Clinic Q&A: How Does SARS-CoV-2 Make People Sick?

This episode is shared from Mayo Clinic Q&A and was recorded on March 31, 2020.Guest: Gregory Poland, M.D.Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)A novel coronavirus is a new strain that has not been seen before in humans. SARS-Co-V2 is a novel virus, causing the disease COVID-19. Because COVID-19 is a new disease, much is still being learned about how it spreads and the severity of illness it causes.On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, infectious disease expert and head of Mayo Clinic’s Vaccine Research Group, explains the science behind how the virus makes people sick, and what the virus does to the body. Dr. Poland will also discuss the latest information on clinical trials and vaccine research to fight the disease outbreak.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

19 MIN1 d ago
Comments
Mayo Clinic Q&A: How Does SARS-CoV-2 Make People Sick?

A Rheumatologist’s Approach to Osteoarthritis

Guest: Alicia M. Hinze, M.D., M.H.S. (@alicia_hinze)Host: Darryl S. Chutka, M.D. (@ChutkaMD)Alicia M. Hinze, M.D., M.H.S., provides an overview of osteoarthritis and other rheumatologic conditions. Dr. Hinze shares her approach to distinguishing between osteoarthritis and inflammatory arthritis, along with risk factors for developing osteoarthritis over time, including genetics, professions, prior injuries, and age. She shares recommendations for conservative therapies and at what point surgical intervention should be considered.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

21 MIN1 d ago
Comments
A Rheumatologist’s Approach to Osteoarthritis

COVID-19 Miniseries Episode 9: Recommendations on Ibuprofen

This episode was recorded on Monday, March 30, 2020.Claim credit here:https://ce.mayo.edu/covid19podcastGuest: Matthew P. Van Cuyk, Pharm.D., R.Ph.Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)Should we be using ibuprofen to treat patients with COVID-19? Does this fall into the modifiable risk category? Dr. Matthew Van Cuyk breaks down recent events and literature around ibuprofen use in patients with COVID-19.Deeper Dive:Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. March 2020. https://doi.org/10.1016/S2213-2600(20)30116-8HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19ASHP Coronavirus Resource Center: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/CoronavirusAssessment of Evidence for COVID-19-Related Treatments: Updated 3/27/2020For the most up to date COVID-19 information: CDC: https://www.cdc.gov/coronavirus/2019-ncov/inde...

33 MIN2 d ago
Comments
COVID-19 Miniseries Episode 9: Recommendations on Ibuprofen

Mayo Clinic Q&A: Point-of-Care Manufacturing to Help Fight COVID-19

This episode is shared from Mayo Clinic Q&A and was recorded on March 26, 2020.Guest: Jonathan M. Morris, M.D. & Mark WehdeHost: Tom Shives, MD and Tracy McCray (@TracyMcCray)When it comes to fighting the COVID-19 pandemic, Mayo Clinic is relying not only on clinicians, but also engineers. Supply chain management and manufacturing capabilities are being readied to help in the fight against COVID-19.On the Mayo Clinic Q&A podcast, Dr. Jonathan Morris, co-director of Mayo Clinic's 3D Anatomic Modeling Lab, and Mark Wehde, chair of Mayo Clinic's Division of Engineering, discuss personal protective equipment and mobilizing the manufacturing sector to help in the fight. They’ll share how they’re utilizing 3D printing to jump start conventional scalable manufacturing processes to retro-engineer pieces of respiratory equipment and solve today’s problems in the fight against COVID-19.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.ed...

12 MIN2 d ago
Comments
Mayo Clinic Q&A: Point-of-Care Manufacturing to Help Fight COVID-19

COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

This episode was recorded on March 27, 2020.To claim credit visit: https://ce.mayo.edu/covid19podcastGuest: Christina G. Rivera, Pharm.D., R.Ph.; Ryan W. Stevens, Pharm.D. (@Stevens_AK)Host: Raymund R. Razonable, M.D. (@RazonableMD)Chloroquine emerged as an early COVID-19 treatment option in China and there has been increasing interest in the use of hydroxychloroquine and azithromycin. What data is available for the safety and efficacy of the drugs in the fight against SARS-CoV-2? Dr. Christina Rivera and Dr. Ryan Stevens provide a breakdown of recent research.Deeper Dive:Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. March 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment ...

25 MIN5 d ago
Comments
COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

Mayo Clinic Q&A: Shifting from Me to We

This episode is shared from Mayo Clinic Q&A and was recorded on March 25, 2020.Guest: Greg Poland, MD (@drgregpoland)Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)Greg Poland, MD, answers trending questions from listeners. Is it safe to order take-out or have groceries delivered? Can pets get coronavirus? What about our summer plans? What’s next for social distancing and is it working?Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

23 MIN6 d ago
Comments
Mayo Clinic Q&A: Shifting from Me to We

COVID-19 Miniseries Episode 7: Anosmia - What’s Currently Known

This episode was recorded on March 25, 2020.Guest: Erin K. O'Brien, M.D. (@ErinOBrienMD)Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)Claim credit here:https://ce.mayo.edu/covid19podcastWhat’s currently known about anosmia as a symptom of COVID-19 infection? Should we be using it as a screening tool? What causes it to occur when someone is infected with SARS-CoV-2 and what’s the prevalence in symptomatic vs otherwise asymptomatic individuals? Dr. Erin O’Brien gives an up-to-date overview of current reports, treatment options, and what you need to know about anosmia.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

31 MIN1 w ago
Comments
COVID-19 Miniseries Episode 7: Anosmia - What’s Currently Known

COVID-19 Miniseries Episode 6: Mayo Clinic Q&A - The Latest Updates

Guest: Greg Poland, MD (@drgregpoland)Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)Claim credit for this episode athttps://ce.mayo.edu/covid19podcastOn today's Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious disease expert and head of Mayo Clinic's Vaccine Research Group, shares the latest information on the COVID-19 pandemic.Dr. Poland discusses the importance of testing for SARS-CoV-2, work being done on antiviral medications; and how long social distancing might need to last, emerging reports of loss of smell in survivors, and the use of azithromycin and hydroxychloroquine.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

21 MIN1 w ago
Comments
COVID-19 Miniseries Episode 6: Mayo Clinic Q&A - The Latest Updates

Answering any Question You’ve Ever Had About Liver Function Testing

Guest: John J. Poterucha, M.D.Host: Darryl S. Chutka, M.D. (@ChutkaMD)You can think of liver functions tests as falling into two buckets – markers of inflammation and perturbation and markers of liver function. Dr. John Poterucha answers any question you’ve ever had about liver function testing, including how to interpret the results plus when and what additional testing may need to be ordered as follow up.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

19 MIN1 w ago
Comments
Answering any Question You’ve Ever Had About Liver Function Testing

Mayo Clinic Q&A: Coping with Uncertainty

This episode is shared from Mayo Clinic Q&A.Guest: Beth Rush, PhDHost: Tom Shives, MD and Tracy McCray (@TracyMcCray)We are in the midst of uncertain times. Dr. Beth Rush, a Mayo Clinic neuropsychologist, shares tips for you and your patients about coping with uncertainty by creating a structured schedule. Listen in as she shares more tips for taking care of your mental health and finding comfort amid the uncertainty.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

7 MIN1 w ago
Comments
Mayo Clinic Q&A: Coping with Uncertainty

Latest Episodes

Mayo Clinic Q&A: How Does SARS-CoV-2 Make People Sick?

This episode is shared from Mayo Clinic Q&A and was recorded on March 31, 2020.Guest: Gregory Poland, M.D.Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)A novel coronavirus is a new strain that has not been seen before in humans. SARS-Co-V2 is a novel virus, causing the disease COVID-19. Because COVID-19 is a new disease, much is still being learned about how it spreads and the severity of illness it causes.On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, infectious disease expert and head of Mayo Clinic’s Vaccine Research Group, explains the science behind how the virus makes people sick, and what the virus does to the body. Dr. Poland will also discuss the latest information on clinical trials and vaccine research to fight the disease outbreak.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

19 MIN1 d ago
Comments
Mayo Clinic Q&A: How Does SARS-CoV-2 Make People Sick?

A Rheumatologist’s Approach to Osteoarthritis

Guest: Alicia M. Hinze, M.D., M.H.S. (@alicia_hinze)Host: Darryl S. Chutka, M.D. (@ChutkaMD)Alicia M. Hinze, M.D., M.H.S., provides an overview of osteoarthritis and other rheumatologic conditions. Dr. Hinze shares her approach to distinguishing between osteoarthritis and inflammatory arthritis, along with risk factors for developing osteoarthritis over time, including genetics, professions, prior injuries, and age. She shares recommendations for conservative therapies and at what point surgical intervention should be considered.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

21 MIN1 d ago
Comments
A Rheumatologist’s Approach to Osteoarthritis

COVID-19 Miniseries Episode 9: Recommendations on Ibuprofen

This episode was recorded on Monday, March 30, 2020.Claim credit here:https://ce.mayo.edu/covid19podcastGuest: Matthew P. Van Cuyk, Pharm.D., R.Ph.Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)Should we be using ibuprofen to treat patients with COVID-19? Does this fall into the modifiable risk category? Dr. Matthew Van Cuyk breaks down recent events and literature around ibuprofen use in patients with COVID-19.Deeper Dive:Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. March 2020. https://doi.org/10.1016/S2213-2600(20)30116-8HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19ASHP Coronavirus Resource Center: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/CoronavirusAssessment of Evidence for COVID-19-Related Treatments: Updated 3/27/2020For the most up to date COVID-19 information: CDC: https://www.cdc.gov/coronavirus/2019-ncov/inde...

33 MIN2 d ago
Comments
COVID-19 Miniseries Episode 9: Recommendations on Ibuprofen

Mayo Clinic Q&A: Point-of-Care Manufacturing to Help Fight COVID-19

This episode is shared from Mayo Clinic Q&A and was recorded on March 26, 2020.Guest: Jonathan M. Morris, M.D. & Mark WehdeHost: Tom Shives, MD and Tracy McCray (@TracyMcCray)When it comes to fighting the COVID-19 pandemic, Mayo Clinic is relying not only on clinicians, but also engineers. Supply chain management and manufacturing capabilities are being readied to help in the fight against COVID-19.On the Mayo Clinic Q&A podcast, Dr. Jonathan Morris, co-director of Mayo Clinic's 3D Anatomic Modeling Lab, and Mark Wehde, chair of Mayo Clinic's Division of Engineering, discuss personal protective equipment and mobilizing the manufacturing sector to help in the fight. They’ll share how they’re utilizing 3D printing to jump start conventional scalable manufacturing processes to retro-engineer pieces of respiratory equipment and solve today’s problems in the fight against COVID-19.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.ed...

12 MIN2 d ago
Comments
Mayo Clinic Q&A: Point-of-Care Manufacturing to Help Fight COVID-19

COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

This episode was recorded on March 27, 2020.To claim credit visit: https://ce.mayo.edu/covid19podcastGuest: Christina G. Rivera, Pharm.D., R.Ph.; Ryan W. Stevens, Pharm.D. (@Stevens_AK)Host: Raymund R. Razonable, M.D. (@RazonableMD)Chloroquine emerged as an early COVID-19 treatment option in China and there has been increasing interest in the use of hydroxychloroquine and azithromycin. What data is available for the safety and efficacy of the drugs in the fight against SARS-CoV-2? Dr. Christina Rivera and Dr. Ryan Stevens provide a breakdown of recent research.Deeper Dive:Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. March 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment ...

25 MIN5 d ago
Comments
COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

Mayo Clinic Q&A: Shifting from Me to We

This episode is shared from Mayo Clinic Q&A and was recorded on March 25, 2020.Guest: Greg Poland, MD (@drgregpoland)Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)Greg Poland, MD, answers trending questions from listeners. Is it safe to order take-out or have groceries delivered? Can pets get coronavirus? What about our summer plans? What’s next for social distancing and is it working?Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

23 MIN6 d ago
Comments
Mayo Clinic Q&A: Shifting from Me to We

COVID-19 Miniseries Episode 7: Anosmia - What’s Currently Known

This episode was recorded on March 25, 2020.Guest: Erin K. O'Brien, M.D. (@ErinOBrienMD)Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)Claim credit here:https://ce.mayo.edu/covid19podcastWhat’s currently known about anosmia as a symptom of COVID-19 infection? Should we be using it as a screening tool? What causes it to occur when someone is infected with SARS-CoV-2 and what’s the prevalence in symptomatic vs otherwise asymptomatic individuals? Dr. Erin O’Brien gives an up-to-date overview of current reports, treatment options, and what you need to know about anosmia.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

31 MIN1 w ago
Comments
COVID-19 Miniseries Episode 7: Anosmia - What’s Currently Known

COVID-19 Miniseries Episode 6: Mayo Clinic Q&A - The Latest Updates

Guest: Greg Poland, MD (@drgregpoland)Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)Claim credit for this episode athttps://ce.mayo.edu/covid19podcastOn today's Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious disease expert and head of Mayo Clinic's Vaccine Research Group, shares the latest information on the COVID-19 pandemic.Dr. Poland discusses the importance of testing for SARS-CoV-2, work being done on antiviral medications; and how long social distancing might need to last, emerging reports of loss of smell in survivors, and the use of azithromycin and hydroxychloroquine.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

21 MIN1 w ago
Comments
COVID-19 Miniseries Episode 6: Mayo Clinic Q&A - The Latest Updates

Answering any Question You’ve Ever Had About Liver Function Testing

Guest: John J. Poterucha, M.D.Host: Darryl S. Chutka, M.D. (@ChutkaMD)You can think of liver functions tests as falling into two buckets – markers of inflammation and perturbation and markers of liver function. Dr. John Poterucha answers any question you’ve ever had about liver function testing, including how to interpret the results plus when and what additional testing may need to be ordered as follow up.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

19 MIN1 w ago
Comments
Answering any Question You’ve Ever Had About Liver Function Testing

Mayo Clinic Q&A: Coping with Uncertainty

This episode is shared from Mayo Clinic Q&A.Guest: Beth Rush, PhDHost: Tom Shives, MD and Tracy McCray (@TracyMcCray)We are in the midst of uncertain times. Dr. Beth Rush, a Mayo Clinic neuropsychologist, shares tips for you and your patients about coping with uncertainty by creating a structured schedule. Listen in as she shares more tips for taking care of your mental health and finding comfort amid the uncertainty.Connect with the Mayo Clinic’s School of Continuous Professional Developmentonline at https://ce.mayo.edu/oron Twitter @MayoMedEd.

7 MIN1 w ago
Comments
Mayo Clinic Q&A: Coping with Uncertainty
hmly
Welcome to Himalaya Premium